16 episodes

News, interviews and discussion from the 18th European Haematology Association (EHA) Congress in Stockholm, Sweden.

18th European Haematology Association (EHA) Congres‪s‬ ecancer

    • Medicine

News, interviews and discussion from the 18th European Haematology Association (EHA) Congress in Stockholm, Sweden.

    • video
    Carfilzomib plus melphalanprednisone in elderly patients with newly diagnosed multiple myeloma: Prof Philippe Moreau

    Carfilzomib plus melphalanprednisone in elderly patients with newly diagnosed multiple myeloma: Prof Philippe Moreau

    Prof Philippe Moreau talks to ecancer at the 18th EHA Congress about the results of a phase I/II trial that tested carfilzomib plus melphalanprednisone in elderly patients with newly diagnosed multiple myeloma.

    • 2 min
    • video
    JAK-STAT pathway in malignant and non-malignant cells in myeloproliferative neoplasms: Dr Ross Levine

    JAK-STAT pathway in malignant and non-malignant cells in myeloproliferative neoplasms: Dr Ross Levine

    Dr Ross Levine presented results from a study on targeting the JAK-STAT pathway in myeloproliferative neoplasms at the EHA 2013.

    Myeloproliferative neoplasms (MPN) are clonal blood disorders characterised by excessive production of mature blood cells. The identification of somatic mutations in JAK2, MPL and LNK in the majority of MPN patients led to the development of JAK kinase inhibitors. JAK1/2 inhibitors improve splenomegaly and systemic symptoms, however the mechanism by which this occurs in patients has not been elucidated.

    • 4 min
    • video
    Use of autologous stem cell transplant in multiple myeloma: Dr Elena Zamagni

    Use of autologous stem cell transplant in multiple myeloma: Dr Elena Zamagni

    Dr Elena Zamagni talks to ecancer about autologous stem cell transplant at the 18th EHA Congress in Stockholm, Sweden.

    Dr Zamagni highlights the relationship between increasing chemotherapy after transplantation and increasing progression free and overall survival from two clinical trials.

    • 3 min
    • video
    Age and ageing in blood disorders: Prof Pieter Sonneveld

    Age and ageing in blood disorders: Prof Pieter Sonneveld

    Prof Pieter Sonneveld talks to ecancer at the 18th EHA Congress in Stockholm, Sweden about the issues with ageing in blood related cancers.

    Prof Sonneveld highlights several issues with aging in blood disorders and at a higher age people are more likely to get blood cancers. Patients with already with disorders are more likely to develope additional issues.

    • 5 min
    • video
    Relapsed or progressive multiple myeloma - Dr Ruben Niesvizky

    Relapsed or progressive multiple myeloma - Dr Ruben Niesvizky

    Dr Ruben Niesvizky talks to ecancer at the 18th EHA Congress about managment of patients with relapsed or progressive multiple myeloma, including major advances in bring a new agents to the frontline such as immunomodulators, melphalanprednisone, and lenalidomide.

    • 7 min
    • video
    Dr Evan Sadler: Von Willebrand Factor and ADAMTS13: Evan Salder

    Dr Evan Sadler: Von Willebrand Factor and ADAMTS13: Evan Salder

    Dr Evan Sadler talks to ecancer at the 18th EHA Congress to discuss diseases associated with Von Willebrand Factor and ADAMTS13, a protein circulating in the blood that prevents bleeding by collecting platelets.

    • 6 min

Top Podcasts In Medicine

More by ecancer